Jiangsu Zhongbang Pharmaceutical Co Ltd | CAS 144690-92-6 | End Use API | Intermediate

CAS 144690-92-6

Chemistry, 9 End Use API, 27 Related Intermediates

Manufacturers/Suppliers

9 Suppliers

9 Suppliers

MARKET PLACE

1 Intermediates

1 Intermediates

Also known as: 144690-92-6, Trityl olmesartan medoxomil, Triphenyl methyl olmesartan, Trityl olmesartan, N1-tritylolmesartan medoxomil, N-1 trityl olmesartan medoxomil

Molecular Formula

C₄₈H₄₄N₆O₆

Molecular Weight

800.9 g/mol

InChI Key

IJOPLMOXIPGJIJ-UHFFFAOYSA-N

FDA UNII

8591TIT360

1 2D Structure

CAS 144690-92-6

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate

2.1.2 InChI

InChI=1S/C48H44N6O6/c1-5-17-41-49-43(47(3,4)57)42(45(55)58-31-40-32(2)59-46(56)60-40)53(41)30-33-26-28-34(29-27-33)38-24-15-16-25-39(38)44-50-51-52-54(44)48(35-18-9-6-10-19-35,36-20-11-7-12-21-36)37-22-13-8-14-23-37/h6-16,18-29,57H,5,17,30-31H2,1-4H3

2.1.3 InChI Key

IJOPLMOXIPGJIJ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=NN4C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)C(=O)OCC8=C(OC(=O)O8)C)C(C)(C)O

2.2 Other Identifiers

2.2.1 UNII

8591TIT360

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 144690-92-6

2. Trityl Olmesartan Medoxomil

3. Triphenyl Methyl Olmesartan

4. Trityl Olmesartan

5. N1-tritylolmesartan Medoxomil

6. N-1 Trityl Olmesartan Medoxomil

7. 8591tit360

8. (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1h-imidazole-5-carboxylate

9. (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate

10. (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl)-1h-imidazole-5-carboxylate

11. 1h-imidazole-5-carboxylic Acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1-(triphenylmethyl)-1h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester

12. 1h-imidazole-5-carboxylic Acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester

13. Unii-8591tit360

14. (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate

15. (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-{trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate

16. 1h-imidazole-5-carboxylic Acid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1-(triphenylmethyl)-1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl)methyl)-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester

17. 1h-imidazole-5-carboxylic Acid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester

18. Ec 604-437-3

19. Schembl1653541

20. Olmesartan Medoxomil Impurity, N-alkyl Impurity- [usp]

21. Dtxsid70162785

22. Mfcd09954745

23. Zinc94313257

24. Akos015896144

25. Ac-3500

26. Am90291

27. Sb41036

28. Quinacrinedihydrochloridedihydrate

29. As-12483

30. Db-063556

31. Cs-0138129

32. Ft-0657780

33. F19426

34. A808264

35. Q27269619

36. Olmesartan Medoxomil Impurity, N-alkyl Impurity- [usp Impurity]

37. (5-methyl -2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate

38. (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1h-imidazole-5-carboxylate

39. 1-[2'-(1-trityl-1h-tetrazole-5-yl)-4-biphenylylmethyl]-2-propyl-4-(1-hydroxy-1-methylethyl)-1h-imidazole-5-carboxylic Acid 2-oxo-5-methyl-1,3-dioxole-4-ylmethyl Ester

40. 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-carboxylic Acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester;trityl Olmesartan Medoxomil

2.4 Create Date

2007-12-04

3 Chemical and Physical Properties

Molecular Formula	C₄₈H₄₄N₆O₆
Molecular Weight	800.9 g/mol
XLogP3	8.7
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	10
Rotatable Bond Count	15
Exact Mass	800.33223314 g/mol
Monoisotopic Mass	800.33223314 g/mol
Topological Polar Surface Area	144 Å²
Heavy Atom Count	60
Formal Charge	0
Complexity	1420
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Jiangsu Zhongbang Pharmaceutical Co...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

Olmesartan Medoxomil

PDF Supplier PDF

URL Supplier Web Content

CAS Number

144690-92-6

Intermediate Name

TritylOlmesartanMedoxomil

About the Company

Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...

Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.

ASK
US